Characteristics of adherent and non-adherent patients with hypertension in a Norwegian cross-sectional study

Aim: Non-adherence is an important cause of uncontrolled hypertension. We investigated the prevalence of non-adherence to antihypertensive medications by serum drug concentration measurements in a cohort of Norwegian patients from the general population treated for hypertension. We also identified c...

Full description

Saved in:
Bibliographic Details
Main Authors: Eirik Olsen, Lene V. Halvorsen, Stine Rognstad, Arleen Aune, Karl Marius Brobak, Ola Undrum Bergland, Vibeke N. Kjær, Knut Liestøl, Marit D. Solbu, Rune Mo, Eva Gerdts, Morten Rostrup, Sverre E. Kjeldsen, Aud Høieggen, Mimi S. Opdal, Anne Cecilie K. Larstorp, Camilla L. Søraas
Format: Article
Language:English
Published: Open Exploration Publishing Inc. 2025-02-01
Series:Exploration of Medicine
Subjects:
Online Access:https://www.explorationpub.com/uploads/Article/A1001279/1001279.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825199302461358080
author Eirik Olsen
Lene V. Halvorsen
Stine Rognstad
Arleen Aune
Karl Marius Brobak
Ola Undrum Bergland
Vibeke N. Kjær
Knut Liestøl
Marit D. Solbu
Rune Mo
Eva Gerdts
Morten Rostrup
Sverre E. Kjeldsen
Aud Høieggen
Mimi S. Opdal
Anne Cecilie K. Larstorp
Camilla L. Søraas
author_facet Eirik Olsen
Lene V. Halvorsen
Stine Rognstad
Arleen Aune
Karl Marius Brobak
Ola Undrum Bergland
Vibeke N. Kjær
Knut Liestøl
Marit D. Solbu
Rune Mo
Eva Gerdts
Morten Rostrup
Sverre E. Kjeldsen
Aud Høieggen
Mimi S. Opdal
Anne Cecilie K. Larstorp
Camilla L. Søraas
author_sort Eirik Olsen
collection DOAJ
description Aim: Non-adherence is an important cause of uncontrolled hypertension. We investigated the prevalence of non-adherence to antihypertensive medications by serum drug concentration measurements in a cohort of Norwegian patients from the general population treated for hypertension. We also identified characteristics associated with non-adherence. Methods: Patients with hypertension using ≥ 2 antihypertensive agents were invited to participate in this national study performed in a semi-blinded fashion. Exclusion criteria were dementia, substance or alcohol abuse, pregnancy, terminal illnesses, poor Norwegian language skills, or severe kidney failure [glomerular filtration rate (GFR) < 30 mL/min/1.73 m2]. All patients had their antihypertensive drugs in serum analyzed by ultra-high-pressure liquid chromatography-tandem mass spectrometry to identify their adherence to the 23 most used antihypertensive agents. Additionally, they underwent a thorough standardized interview, office blood pressure (BP), and 24-hour ambulatory BP measurement. Results: n = 1,151 patients were investigated for BP control and drug adherence. Among these, n = 79 (6.9%) patients were identified as non-adherent, and n = 1,072 (93.1%) patients were identified as adherent by pharmacologists who reviewed the drug concentrations in blood in relation to self-reported prescribed medications. We found the non-adherent patients to be younger (56.9 vs. 63.7 years, p < 0.001), with higher systolic and diastolic office BP (150.4/91.4 vs. 143.2/82.0 mmHg, p < 0.01) and less likely to be of European ethnicity (82.9% vs. 95.8%, p < 0.001). Factors associated with non-adherence in logistic regression analysis were age, number of antihypertensive pills, non-European ethnicity, and inversely the use of angiotensin receptor blockers. Conclusions: We found fewer non-adherent patients than expected in patients on ≥ 2 antihypertensive drugs compared to previous investigations of patients on ≥ 3 antihypertensive drugs. We believe that selection at inclusion or possibly a higher confidence in physicians’ authority may be of importance. Adherence was significantly and negatively related to younger age, non-European ethnicity, and increasing number of prescribed antihypertensive pills, and positively to the type of prescribed medication, especially angiotensin receptor blocker (www.ClinicalTrials.gov identifier: NCT03209154).
format Article
id doaj-art-f35e80da443741939e70acb20758df93
institution Kabale University
issn 2692-3106
language English
publishDate 2025-02-01
publisher Open Exploration Publishing Inc.
record_format Article
series Exploration of Medicine
spelling doaj-art-f35e80da443741939e70acb20758df932025-02-08T05:26:23ZengOpen Exploration Publishing Inc.Exploration of Medicine2692-31062025-02-016100127910.37349/emed.2025.1001279Characteristics of adherent and non-adherent patients with hypertension in a Norwegian cross-sectional studyEirik Olsen0https://orcid.org/0009-0008-6187-658XLene V. Halvorsen1https://orcid.org/0000-0003-0411-2459Stine Rognstad2Arleen Aune3https://orcid.org/0000-0002-6363-9819Karl Marius Brobak4https://orcid.org/0000-0001-7104-1764Ola Undrum Bergland5Vibeke N. Kjær6Knut Liestøl7https://orcid.org/0000-0002-7929-582XMarit D. Solbu8https://orcid.org/0000-0002-4331-7548Rune Mo9Eva Gerdts10Morten Rostrup11Sverre E. Kjeldsen12https://orcid.org/0000-0003-2389-0272Aud Høieggen13Mimi S. Opdal14https://orcid.org/0000-0002-7011-9811Anne Cecilie K. Larstorp15https://orcid.org/0000-0002-0223-9248Camilla L. Søraas16https://orcid.org/0000-0002-3964-4351Norwegian University of Science and Technology, 7030 Trondheim, Norway; Department of Cardiology, St. Olav’s University Hospital, 7030 Trondheim, NorwaySection for Cardiovascular and Renal Research, Ullevaal University Hospital, 0424 Oslo, Norway; Department of Nephrology, Ullevaal University Hospital, 0424 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, 0316 Oslo, NorwaySection for Cardiovascular and Renal Research, Ullevaal University Hospital, 0424 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, 0316 Oslo, Norway; Department of Pharmacology, Ullevaal University Hospital, 0424 Oslo, NorwayDepartment of Clinical Science, University of Bergen, 5020 Bergen, Norway; Department of Heart Disease, Haukeland University Hospital, 5021 Bergen, NorwayMetabolic and Renal Research Group, UiT The Arctic University of Norway, 9037 Tromsø, Norway; Section of Nephrology, University Hospital of North Norway, 9038 Tromsø, NorwaySection for Cardiovascular and Renal Research, Ullevaal University Hospital, 0424 Oslo, NorwaySection for Cardiovascular and Renal Research, Ullevaal University Hospital, 0424 Oslo, NorwayDepartment of Informatics, University of Oslo, 0316 Oslo, NorwayMetabolic and Renal Research Group, UiT The Arctic University of Norway, 9037 Tromsø, Norway; Section of Nephrology, University Hospital of North Norway, 9038 Tromsø, NorwayNorwegian University of Science and Technology, 7030 Trondheim, Norway; Department of Cardiology, St. Olav’s University Hospital, 7030 Trondheim, NorwayDepartment of Clinical Science, University of Bergen, 5020 Bergen, Norway; Department of Heart Disease, Haukeland University Hospital, 5021 Bergen, NorwaySection for Cardiovascular and Renal Research, Ullevaal University Hospital, 0424 Oslo, Norway; Institute of Behavioral Sciences in Medicine, University of Oslo, 0316 Oslo, Norway; Department of Acute Medicine, Ullevaal University Hospital, 0424 Oslo, NorwaySection for Cardiovascular and Renal Research, Ullevaal University Hospital, 0424 Oslo, Norway; Department of Nephrology, Ullevaal University Hospital, 0424 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, 0316 Oslo, Norway; Department of Cardiology, Ullevaal University Hospital, 0424 Oslo, NorwaySection for Cardiovascular and Renal Research, Ullevaal University Hospital, 0424 Oslo, Norway; Department of Nephrology, Ullevaal University Hospital, 0424 Oslo, NorwayInstitute of Clinical Medicine, University of Oslo, 0316 Oslo, Norway; Department of Pharmacology, Ullevaal University Hospital, 0424 Oslo, NorwaySection for Cardiovascular and Renal Research, Ullevaal University Hospital, 0424 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, 0316 Oslo, Norway; Department of Medical Biochemistry, Ullevaal University Hospital, 0424 Oslo, NorwaySection for Cardiovascular and Renal Research, Ullevaal University Hospital, 0424 Oslo, Norway; Section for Environmental and Occupational Medicine, Ullevaal University Hospital, 0424 Oslo, NorwayAim: Non-adherence is an important cause of uncontrolled hypertension. We investigated the prevalence of non-adherence to antihypertensive medications by serum drug concentration measurements in a cohort of Norwegian patients from the general population treated for hypertension. We also identified characteristics associated with non-adherence. Methods: Patients with hypertension using ≥ 2 antihypertensive agents were invited to participate in this national study performed in a semi-blinded fashion. Exclusion criteria were dementia, substance or alcohol abuse, pregnancy, terminal illnesses, poor Norwegian language skills, or severe kidney failure [glomerular filtration rate (GFR) < 30 mL/min/1.73 m2]. All patients had their antihypertensive drugs in serum analyzed by ultra-high-pressure liquid chromatography-tandem mass spectrometry to identify their adherence to the 23 most used antihypertensive agents. Additionally, they underwent a thorough standardized interview, office blood pressure (BP), and 24-hour ambulatory BP measurement. Results: n = 1,151 patients were investigated for BP control and drug adherence. Among these, n = 79 (6.9%) patients were identified as non-adherent, and n = 1,072 (93.1%) patients were identified as adherent by pharmacologists who reviewed the drug concentrations in blood in relation to self-reported prescribed medications. We found the non-adherent patients to be younger (56.9 vs. 63.7 years, p < 0.001), with higher systolic and diastolic office BP (150.4/91.4 vs. 143.2/82.0 mmHg, p < 0.01) and less likely to be of European ethnicity (82.9% vs. 95.8%, p < 0.001). Factors associated with non-adherence in logistic regression analysis were age, number of antihypertensive pills, non-European ethnicity, and inversely the use of angiotensin receptor blockers. Conclusions: We found fewer non-adherent patients than expected in patients on ≥ 2 antihypertensive drugs compared to previous investigations of patients on ≥ 3 antihypertensive drugs. We believe that selection at inclusion or possibly a higher confidence in physicians’ authority may be of importance. Adherence was significantly and negatively related to younger age, non-European ethnicity, and increasing number of prescribed antihypertensive pills, and positively to the type of prescribed medication, especially angiotensin receptor blocker (www.ClinicalTrials.gov identifier: NCT03209154).https://www.explorationpub.com/uploads/Article/A1001279/1001279.pdfadherenceantihypertensive medicationblood pressurehypertension
spellingShingle Eirik Olsen
Lene V. Halvorsen
Stine Rognstad
Arleen Aune
Karl Marius Brobak
Ola Undrum Bergland
Vibeke N. Kjær
Knut Liestøl
Marit D. Solbu
Rune Mo
Eva Gerdts
Morten Rostrup
Sverre E. Kjeldsen
Aud Høieggen
Mimi S. Opdal
Anne Cecilie K. Larstorp
Camilla L. Søraas
Characteristics of adherent and non-adherent patients with hypertension in a Norwegian cross-sectional study
Exploration of Medicine
adherence
antihypertensive medication
blood pressure
hypertension
title Characteristics of adherent and non-adherent patients with hypertension in a Norwegian cross-sectional study
title_full Characteristics of adherent and non-adherent patients with hypertension in a Norwegian cross-sectional study
title_fullStr Characteristics of adherent and non-adherent patients with hypertension in a Norwegian cross-sectional study
title_full_unstemmed Characteristics of adherent and non-adherent patients with hypertension in a Norwegian cross-sectional study
title_short Characteristics of adherent and non-adherent patients with hypertension in a Norwegian cross-sectional study
title_sort characteristics of adherent and non adherent patients with hypertension in a norwegian cross sectional study
topic adherence
antihypertensive medication
blood pressure
hypertension
url https://www.explorationpub.com/uploads/Article/A1001279/1001279.pdf
work_keys_str_mv AT eirikolsen characteristicsofadherentandnonadherentpatientswithhypertensioninanorwegiancrosssectionalstudy
AT lenevhalvorsen characteristicsofadherentandnonadherentpatientswithhypertensioninanorwegiancrosssectionalstudy
AT stinerognstad characteristicsofadherentandnonadherentpatientswithhypertensioninanorwegiancrosssectionalstudy
AT arleenaune characteristicsofadherentandnonadherentpatientswithhypertensioninanorwegiancrosssectionalstudy
AT karlmariusbrobak characteristicsofadherentandnonadherentpatientswithhypertensioninanorwegiancrosssectionalstudy
AT olaundrumbergland characteristicsofadherentandnonadherentpatientswithhypertensioninanorwegiancrosssectionalstudy
AT vibekenkjær characteristicsofadherentandnonadherentpatientswithhypertensioninanorwegiancrosssectionalstudy
AT knutliestøl characteristicsofadherentandnonadherentpatientswithhypertensioninanorwegiancrosssectionalstudy
AT maritdsolbu characteristicsofadherentandnonadherentpatientswithhypertensioninanorwegiancrosssectionalstudy
AT runemo characteristicsofadherentandnonadherentpatientswithhypertensioninanorwegiancrosssectionalstudy
AT evagerdts characteristicsofadherentandnonadherentpatientswithhypertensioninanorwegiancrosssectionalstudy
AT mortenrostrup characteristicsofadherentandnonadherentpatientswithhypertensioninanorwegiancrosssectionalstudy
AT sverreekjeldsen characteristicsofadherentandnonadherentpatientswithhypertensioninanorwegiancrosssectionalstudy
AT audhøieggen characteristicsofadherentandnonadherentpatientswithhypertensioninanorwegiancrosssectionalstudy
AT mimisopdal characteristicsofadherentandnonadherentpatientswithhypertensioninanorwegiancrosssectionalstudy
AT annececilieklarstorp characteristicsofadherentandnonadherentpatientswithhypertensioninanorwegiancrosssectionalstudy
AT camillalsøraas characteristicsofadherentandnonadherentpatientswithhypertensioninanorwegiancrosssectionalstudy